CSIMarket
 
Intelligent Medicine Acquisition Corp   (IQMD)
Other Ticker:  
 
    Sector  Financial    Industry Blank Checks
   Industry Blank Checks
   Sector  Financial
 

Intelligent Medicine Acquisition Growth Comparisons

Select each growth Category to receive further Information



IQMD Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q4 MRQ) - - - 5.63 %
Q / Q Revenue Growth (Q4 MRQ) - -15.19 % - 0.88 %
Y / Y Revenue Growth (for 12 months ending Q4 TTM) - 235.47 % -72.93 % %
Seq. Revenue Growth (for 12 months ending Q4 TTM) - 23.43 % -73.83 % 1.48 %
Revenue 5 Year Average Growth - 28.84 % 9.83 % 11.17 %


IQMD's Growth Comparisons in IV. Quarter 2022




Intelligent Medicine Acquisition reported top-line of $ 0 millions in the forth quarter 2022, compare to $ 0 millions in the same quarter a year ago. Revenues in the Blank Checks industry fell by %, while the top-line in the Financial sector decreased by %, and overall market improved by 5.63% from the forth quarter 2021.

Sequentially company's Revenue were unchanged from the third quarter results. . Looking into annual growth, sales grew by % on average in last five years, while S & P 500's including only Businesses with the forth quarter 2022 earnings reports, average yearly sales growth is 11.17%.


Growth Rates of IQMD's Income in the forth quarter 2022


IQMD Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q4 MRQ) - - - -20.07 %
Seq. Operating Income Change (Q4 MRQ) - - - -6.72 %
Y / Y Operating Income Growth (Q4 TTM) - - - 3.51 %
Seq. Operating Income Growth (Q4 TTM) - - - -5.38 %
Operating Income 5 Year Avg. Change - - 10.25 % 10.91 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q4 MRQ) 3778732 % - -38.79 % -21.04 %
Seq. Income from Cont. Ops. Change (Q4 MRQ) 128.12 % 10.45 % 23.24 % -17.27 %
Y / Y Income from Cont. Ops. Change (Q4 TTM) -52.09 % - -38.63 % -3.14 %
Seq. Income from Cont. Ops. Change (Q4 TTM) 33.05 % 68.87 % -16.74 % -5.49 %
Income from Cont. Ops. 5 Year Avg. Change - - 3.41 % 2.86 %

IQMD Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q4 MRQ) 3778732 % - -40.05 % -19.16 %
Q / Q Net Income Growth (Q4 MRQ) 128.12 % 10.45 % 22.8 % -15.62 %
Y / Y Net Income Change (Q4 TTM) -52.09 % - -39.22 % -4.05 %
Seq. Net Income Change (Q4 TTM) 33.05 % 68.87 % -17.28 % -5.07 %
Net Income 5 Year Avg. Growth - - 3.64 % 3.14 %

IQMD's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q4 MRQ) 1086174.55 % - -38.79 % -21.04 %
Seq. EPS from Cont. Ops. Change (Q4 MRQ) 1269.14 % -26.89 % 23.24 % -17.27 %
Y / Y EPS from Cont. Ops. Change (Q4 TTM) -77.71 % - - -
Seq. EPS from Cont. Ops. Change (Q4 TTM) 48.89 % - - -36.1 %
EPS from Cont. Ops. 5 Year Avg. Growth - - 3.41 % 2.86 %



IQMD EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q4 MRQ) 609273.53 % - -40.05 % -19.16 %
Q / Q EPS Net Growth (Q4 MRQ) -23.19 % -26.89 % 22.8 % -15.62 %
Y / Y EPS Net Change (for 12 months ending Q4 TTM) - - - -99.83 %
Seq. EPS Net Change (for 12 months ending Q4 TTM) 20.75 % - - -99.83 %
EPS Net 5 Year Avg. Change - - 3.64 % 3.14 %



Intelligent Medicine Acquisition reported bottom-line of $ 0.08 in the forth quarter, compare to $ 0.00 in the same quarter a year ago. Blank Checks industry fell by %, while Financial sector decreased by -40.05%, and overall market declined by -19.16%.

Comparing the company's EPS to the third quarter results, income per share were lower by -23.19% . On the annual basis, average annual income per share growth for Intelligent Medicine Acquisition is %, while S & P 500's including only Businesses with the forth quarter 2022 financial reports, average yearly income per share growth is 3.14% over the past five years.

IQMD Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q4 MRQ) - - 2.23 % -2.5 %
Seq. Free Cash Flow Change (Q4 MRQ) - - 28.89 % 26.14 %
Y / Y Free Cash Flow Change (Q4 TTM) - - -8.92 % 0.31 %
Seq. Free Cash Flow Change (Q4 TTM) - - 2.13 % -2.58 %
Free Cash Flow 5 Year Avg. Change - - 32.07 % 23.33 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q4 MRQ) 0 % -52.29 % - -
Seq. Net Cash Flow Change (Q4 MRQ) - - - -
Y / Y Net Cash Flow Change (Q4 TTM) -0 % - -77.78 % -
Seq. Net Cash Flow Change (Q4 TTM) - - - -
Net Cash Flow 5 Year Avg. Change - 69.8 % 120.44 % 49.07 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q4 MRQ) - -99.83 % 4.29 % 0.91 %
Seq. Capital Expenditures Change (Q4 MRQ) - -99.9 % 189.1 % 90.44 %
Y / Y Capital Expenditures Change (Q4 TTM) - - -37.63 % 0.15 %
Seq. Capital Expenditures Change (Q4 TTM) - - -23.91 % -1.55 %
Capital Expenditures 5 Year Avg. Change -